Introduction
The Clara cell is one of the most heterogeneous and multifunctional cell types of the mammalian lung, showing a great interspecies variability in abundance and spatial distribution. Clara cells are localized mainly in the proximal, or central, portion of the pulmonary acinus, at the junction between the conducting airways and the gasexchange area. The functions of Clara cells are mainly orientated to the protection of the respiratory tract. Clara cells act as stem cells in the repair of the bronchial epithelium, have a high xenobiotic biotransformation capacity and secrete several substances with important biological activities [1] .
One of the major proteins secreted by Clara cells is the 16 kDa Clara cell protein (CC16) [2] . Even though the exact in vivo function of the CC16 remains to be clari®ed, there is growing evidence that this protein plays a protective role against pulmonary in¯ammatory response. From a diagnostic perspective, CC16 is also at the origin of a novel approach for assessing the integrity of the respiratory epithelium, based on the assay in serum of lung-speci®c proteins [3±5] . As shown by various clinical and experimental studies, the determination of CC16 in serum is a new sensitive marker to detect early permeability changes of the lung epithelial barrier and/or to evaluate the integrity of Clara cells, a privileged target of many pneumotoxicants. mammaglobin and rabbit uteroglobin. Interspecies homologues of the CC16 are referred in the literature by different names which allude to their origin [human protein-1, urine protein-1, uteroglobin (UG), Clara cell secretory protein (CCSP)], their molecular weight [CC16, Clara cell 17 kDa protein, Clara cell 10 kDa protein (CC10)] or their biological property (Blastokinin, Clara cell phospholipid-binding protein, PCB-binding protein). The human CC16, ®rst identi®ed in urine of patients with renal failure [6] and puri®ed later from lung lavage [7] , is the counterpart of rabbit UG, a secretory protein of the lung (both sexes) and the uterus (during pregnancy) of lagomorphs (rabbits, hares) [8] . The amino acid sequence of CC16 presents a high similarity with CC16 from other mammalian species (monkey, rodents), indicating a high level of phylogenic conservation and suggesting a physiological importance [9] . Although unreduced CC16 shows an apparent molecular weight of about 10 kDa on gel electrophoresis its exact molecular mass, determined by electrospray ionization/ mass spectrometry, is 15 840 Da [2] .
The entire human CC16 gene has been sequenced and localized to chromosome 11, p12-q13, a region occupied by several genes involved in the regulation of allergy and in¯ammation. The CC16 gene is comprised of three short exons separated by a long ®rst and short second intron and is controlled by the combinatorial action of the cell-speci®c factor HNF3a and the ubiquitous factor Sp1 [10] . In both humans and rodents, CC16 mRNAs are found in the respiratory airways (tracheal, bronchial and bronchiolar regions) but not in the alveolar epithelium [11] . We showed by Masterblot mRNA analysis that CC16 is also expressed in the prostate, the endometrium, the fetal lung and the kidney [5] . In the rabbit uterus, UG synthesis is regulated by progesterone whereas in the lung, UG production is completely independent of such compounds. UG gene expression is positively controlled by glucocorticoids in the lung, due to the presence of a glucocorticoid receptor binding site in the DNA region upstream from the 5 H -end of UG gene [12] .
CC16 is a homodimer formed by two identical antiparallel chains of 70 amino acid residues, each joined by two disulphide bonds. The appearance of the homodimer is globular, with a large hydrophobic pocket in the central position between the two chains [13] . CC16 is one of the major proteins secreted by the respiratory epithelium. In human bronchoalveolar lavage¯uid (BALF) the concentration of CC16 is, on average, between 1 and 2 mg/l, which represents 2±3% of the total soluble protein content of BALF [2] . Since the lavage technique results in an approximately 100-fold dilution, CC16 concentrations in the epithelium lining¯uid (ELF) can be estimated at about 100 mg/L. In serum from healthy non-smokers, CC16 concentrations are, on average, between 10 and 15 mg/l, i.e. a value approximately 10 000 times lower than in ELF. This huge concentration gradient probably provides the driving force for the movement of CC16 from the lung into the blood [5] . In rodents, CC16 follows the same metabolic pathway as in humans, also leaking from the respiratory tract into serum from where it is rapidly cleared by the kidneys [14] .
Biological properties of CC16
In vitro studies
One of the ®rst studied properties of CC16 (UG) is its ability to carry progesterone, allowing the transfer of this molecule between the uterus and the blastocysts [13] . The af®nity of CC16 for progesterone shows a great interspecies variation which seems to be linked to differences in the amino-acid sequences. Human CC16 can bind progesterone whereas for the monkey CC16 the substitution of two polar residues abolishes the af®nity of the protein for progesterone [9] . Although human CC16 does not bind steroids (or corticosteroids), the hydrophobic pocket may be occupied by lipids (phosphatidylcholine and phosphatidylinositol) or lypophilic xenobiotics, among which are the widespread pollutants polychlorinated biphenyls (PCBs) [15] . This led to the hypothesis that CC16 could facilitate in the accumulation of PCBs in the respiratory tract, explaining chronic pulmonary disease observed in PCBs-exposed workers [16] .
CC16 is a potent natural immunosuppressor and antiin¯ammatory agent. In vitro, CC16 inhibits both monocyte and polymorphonuclear neutrophils chemotaxis and phagocytosis [13] . CC16 also inhibits ®broblast chemotaxis in a dose-dependent manner, an effect which is related to a blockage of cytosolic PLA 2 activity [17] . Human and rat CC16 as well as rabbit UG have been shown to inhibit the activity of secretory and intracellular PLA 2 [18] . Interestingly, PLA 2 enzymes are a family of esterases which are involved in various physiological and pathological processes, controlling the production of arachidonic acid and the availability of prostaglandins and leukotrienes [19] . In this way, PLA 2 inhibition could attenuate the progression of the in¯ammation and also reduce the degradation of lung surfactant phospholipids, thereby preventing the development of chronic lung disease [20] . In addition, by inhibiting secretory PLA 2 activity and decreasing the level of lysophosphatidic acid in the alveolar spaces, CC16 may indirectly reduce the activation of integrins (e.g. a5b1) that enhance abnormal tissue deposition of ®bronectin (Fn) and ®broblast migration. CC16 presents a natural af®nity for ®bronectin but the physiopathological signi®cance of this property is controversial at present [21, 22] . A recent study has also raised the possibility that CC16, through its binding properties, plays critical roles in the regulation of cellular motility and extracellular matrix invasion by cancer cells [23] .
Several studies show a link between CC16 and the cytokine network. CC16 inhibits in vitro both the production and the biological activity of interferon-gamma (IFNg), a potent multi-functional cytokine produced in the course of viral infections and in¯ammation [24] . Conversely, IFN-g has been found to increase the expression of CC16 mRNA in the mouse lung and the CC16 protein levels in cultured human airway epithelial cells [25, 26] . Another cytokine, tumour necrosis factor-a (TNF-a), stimulates CC16 production by bronchial epithelial cells in vitro [27] . Interestingly, IFN-g has been shown to induce the activation of cytosolic PLA 2 in a human bronchial epithelial cell line [28] whereas TNF-a priming causes the secretion of PLA 2 by in¯ammatory cells [29] .
In vivo studies
Recently, it has been proposed that tolerance to long-term ozone (O 3 ) exposure might be due to a site-speci®c elevation of CC16 in the Clara cells, as observed in rats exposed for 90 days to 0.12 p.p.m. O 3 [30] . Studies using CC16-de®cient mice reinforce the hypothesis that CC16 is involved in the protection against oxidative stress, and also in the modulation of lung in¯ammation during viral infection. In mice, CC16 de®ciency is associated with increased susceptibility to lung epithelial damage induced by O 3 [31] and hyperoxia [32] , as evidenced by a higher incidence of mortality, early onset of lung oedema and induction of pro-in¯ammatory cytokine mRNAs. Mice de®cient for CC16 develop also a much more severe lung in¯ammation following acute viral infection. Interestingly, histological evidence of pulmonary in¯ammation in de®-cient mice was associated with increased production of interleukin-1b and À6 and TNF-a, as well as chemokine (macrophage in¯ammatory proteins and monocyte chemoattractant protein-1) mRNAs expression within the lung [33] .
CC16 in asthma and other lung disorders
The CC16 gene is localized to a region of the chromosome 11 known to be occupied by the b-subunit of the highaf®nity immunoglobulin E receptor [34] and various genes involved in the regulation of in¯ammation [11] . A polymorphism in the 5 H -untranslated region of exon 1 of the CC16 gene has recently been associated with an increased risk of asthma in childhood, homozygous and heterozygous subjects demonstrating a 6.9-fold and 4.2-fold increased risk of developing asthma, respectively [35] . Of interest, the mutation is associated with a signi®cant decrease of the serum concentration of CC16 [36] . This observation is in agreement with a previous work, showing that the mean CC16 concentration in BALF of asthmatics was signi®-cantly decreased compared with control healthy subjects [37] . In serum, asthmatic patients with a long duration of the disease ($ 10 years) had signi®cantly lower CC16 levels than those with a short duration of the disease (< 10 years) [38] .
Changes of CC16 concentrations in BALF and/or serum have also been studied in other human lung diseases (for a review, see [5] ). Pulmonary ®brosis has been associated with decreased BALF CC16 levels [39] . In the acute respiratory distress syndrome, CC16 was found in higher concentrations in BALF from patients who survived compared to those who did not [40] .
CC16 as lung peripheral biomarker
Most biomarkers of lung in¯ammation or injury described so far are constituents of the epithelial lining¯uid sampled by bronchoalveolar lavage techniques. These biomarkers consist of plasma-derived proteins or molecules produced locally by the epithelial and in¯ammatory cells such as cytokines, enzymes or growth factors. Although of great potential for evaluating the extent of in¯ammation or tissue damage, markers in BAL are not applicable for monitoring populations exposed to ambient air pollutants in the environment or in the workplace. Also, they cannot be used for assessing health risks in children and patients with compromised cardiopulmonary function, who are the most vulnerable to air pollution.
Studies carried out with CC16 have led to the development of a new non-invasive approach for detecting acute or chronic effects on the respiratory epithelium. This approach is based on the concept that lung secretory proteins move passively across the epithelial barrier into serum where they may serve as peripheral indicators of epithelium damage [3±5,40] . As reviewed hereafter, the concentration of CC16 in serum is a sensitive marker of increased permeability of the lung epithelial barrier or, when the latter is intact, of a loss of integrity or a reduction of Clara cells.
Acute lung injury
Acute damage to Clara cells can be produced experimentally by various pneumotoxicants such as MMT or 4-ipomeanol [41] . These chemicals induce a decrease of Clara cell numbers with an ensuing reduction of both CC16 mRNA and CC16 protein levels in the lung. In contrast, these effects are associated with an increase of serum concentration of CC16, which correlates with the concentration of albumin in BALF. Similar observations have been made with O 3 . Acute exposure of mice and rats to O 3 produces a transient dose-dependent elevation of CC16 in serum (Fig. 1) , which also parallels the elevation of albumin in BAL. At high exposure levels, this effect is found despite a decreased production of CC16 from damaged Clara cells. The O 3 -induced intravascular leakage of CC16 correlates with mouse susceptibility to O 3 . Still more interesting, in the most sensitive strain, this effect was detectable before the elevation of albumin in BAL from exposure levels to O 3 as low as 0.08 p.p.m. during 2 h. These observations indicate that the assay of serum CC16 allows the detection of very subtle defects in the epithelial barrier permeability which are not re¯ected accurately by the levels of albumin in BALF. The explanation for the greater sensitivity of serum CC16 to increased permeability of the epithelial barrier most probably lies in the small size and the huge transepithelial concentration gradient of CC16 compared to that of albumin.
In humans, acute exposure to lung irritants also produces an increase of CC16 in serum. A transient elevation of serum CC16 has been found in ®re®ghters after 20 min of smoke inhalation [42] . Of interest, this increase was found in the absence of any functional signs of lung impairment. The high sensitivity of serum CC16 to lung epithelium injury was con®rmed in a recent study on cyclists exposed to ambient O 3 ( Fig. 2; [43] ). The determination of CC16 before and after a 2-h ride during episodes of photochemical smog (O 3 levels between 0.033 and 0.103 p.p.m.) revealed that ambient O 3 exposure produces a dose-dependent increase of airway permeability at exposure levels below air quality guidelines. However, the most remarkable ®nd-ing was that in humans serum CC16 shows a sensitivity to O 3 almost identical to that observed in mice. Indeed, in both species, the protein rose in serum after only a few hours of exposure to average O 3 levels around 0.08 p.p.m.
Chronic lung injury and occupational disorders
The determination of serum CC16 can also be used to evaluate the chronic effects of air pollutants on the respiratory epithelium. The concentration of CC16 in serum is decreased in a dose-dependent manner by tobacco smoking, the concentration of the protein decreasing on average by 15% for each 10 pack-years [44] . This effect which has been found consistently in several studies is the re¯ection of a concomitant reduction of CC16 in lung lavage due to the progressive decline of Clara cell numbers (Fig. 3 [45] ). A signi®cant reduction of serum CC16 has also been found in workers exposed to crystalline silica [46] and foundry dust (to be published). In most studies these changes were found in asymptomatic subjects with a normal or only a slightly impaired spirometric tests.
Conclusions
The studies on CC16 open exciting perspectives both as a mediator of in¯ammation and as a new peripheral lung marker. In vitro and in vivo experimental studies show that it presents interesting biological properties, suggesting an important protective role of this protein in in¯ammation and oxidative stress. Studies in humans and animals also indicate that the assay of CC16 is a sensitive noninvasive test allowing the detection of early damage to the respiratory epithelium caused by acute or chronic exposure. Advantages of this new test include sensitivity, speci®city, repeatability and applicability to the whole population in, respectively, their age, condition of exposure and type and severity of lung disorders. Fig. 3 . Concentrations of Clara cell protein (CC10, CC16) in serum (upper graph) and BALF (middle graph) and Clara cell density in bronchiolar epithelium (lower graph) from healthy non-smokers and smokers. Horizontal and vertical bars show mean and SD, respectively. Signi®cant differences were found between nonsmokers and smokers in serum CC16 (P < 0.0001), BALF CC16 (P < 0.01) and CC16-positive cells (P < 0.001). 
